Craft

Cipher Pharmaceuticals

Stock Price

$15.7

2024-10-29

Market Capitalization

$401.7 M

2024-10-29

Revenue

$50.5 M

FY, 2025

Cipher Pharmaceuticals Summary

Company Summary

Overview
Cipher Pharmaceuticals is a specialty pharmaceutical company with a portfolio of commercial and early to late-stage products. It focuses on acquiring drug products, managing the required clinical development and regulatory approval processes, and marketing medications. The company provides drug candidates dedicated to dermatology, hospital acute care, gastroenterology, and other therapeutic areas.
Type
Public
Status
Active
Founded
2000
HQ
Oakville, CA | view all locations
Website
https://www.cipherpharma.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • Oakville, ON HQ

    Canada

    501-209 Oak Park Blvd

Cipher Pharmaceuticals Financials

Summary Financials

Revenue (Q1, 2026)
$12.5M
Gross profit (Q1, 2026)
$10.3M
Net income (Q1, 2026)
$6.2M
Cash (Q1, 2026)
$6.4M
EBIT (Q1, 2026)
$5.7M

Footer menu